Ois Podcast
A Visionary Approach to Uveitis: Tarsier Pharma’s Disruptive Innovation
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:29:05
- Mas informaciones
Informações:
Sinopsis
In this OIS Podcast episode, host Dr. Robert Rothman sits down with Daphne Haim-Langford, PhD, Founder & CEO of Tarsier Pharma, and Ashley Kline, Chief Commercial Officer, to discuss their groundbreaking approach to uveitis treatment.Tarsier’s lead candidate, TRS01, is a first-in-class bio-inspired therapy designed to control inflammation without raising intraocular pressure, a major complication of steroid treatments. With a unique mechanism of action that modulates macrophages and reduces inflammation, this novel drug has the potential to redefine uveitis and glaucoma care. In this episode, you’ll learn:
